Current Advances in Chitosan Nanoparticles Based Drug Delivery and Targeting

被引:330
作者
Garg, Unnati [1 ]
Chauhan, Swati [1 ]
Nagaich, Upendra [1 ]
Jain, Neha [1 ]
机构
[1] Amity Univ, Amity Inst Pharm, Sect 125, Noida 201303, Uttar Pradesh, India
关键词
Chitosan; Nanoparticles; Biodegradable; Applications; Drug delivery; NONVIRAL GENE-THERAPY; ORAL DELIVERY; CANCER; SYSTEM; MUCOSAL; VACCINE; NANOCAPSULES; ENHANCEMENT; ABSORPTION; PERMEATION;
D O I
10.15171/apb.2019.023
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nanoparticles (NPs) have been found to be potential targeted and controlled release drug delivery systems. Various drugs can be loaded in the NPs to achieve targeted delivery. Chitosan NPs being biodegradable, biocompatible, less toxic and easy to prepare, are an effective and potential tool for drug delivery. Chitosan is natural biopolymer which can be easily functionalized to obtain the desired targeted results and is also approved by GRAS (Generally Recognized as Safe by the United States Food and Drug Administration [US FDA]). Various methods for preparation of chitosan NPs include, ionic cross-linking, covalent cross-linking, reverse micellar method, precipitation and emulsion-droplet coalescence method. Chitosan NPs are found to have plethora of applications in drug delivery diagnosis and other biological applications. The key applications include ocular drug delivery, per-oral delivery, pulmonary drug delivery, nasal drug delivery, mucosal drug delivery, gene delivery, buccal drug delivery, vaccine delivery, vaginal drug delivery and cancer therapy. The present review describes the formation of chitosan, synthesis of chitosan NPs and their various applications in drug delivery.
引用
收藏
页码:195 / 204
页数:10
相关论文
共 75 条
  • [11] Development and evaluation of Chitosan nanoparticles based dry powder inhalation formulations of Prothionamide
    Debnath, Sujit Kumar
    Saisivam, Srinivasan
    Debanth, Monalisha
    Omri, Abdelwahab
    [J]. PLOS ONE, 2018, 13 (01):
  • [12] Hyaluronic acid-chitosan nanoparticles for co-delivery of M1R-34a and doxorubicin in therapy against triple negative breast cancer
    Deng, Xiongwei
    Cao, Minjun
    Zhang, Jiakun
    Hu, Kelei
    Yin, Zhaoxia
    Zhou, Zhixiang
    Xiao, Xiangqian
    Yang, Yishu
    Sheng, Wang
    Wu, Yan
    Zeng, Yi
    [J]. BIOMATERIALS, 2014, 35 (14) : 4333 - 4344
  • [13] Effect of chitosan on epithelial permeability and structure
    Dodane, V
    Khan, MA
    Merwin, JR
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 182 (01) : 21 - 32
  • [14] Nanoparticle-based drug delivery to the vagina: A review
    Ensign, Laura M.
    Cone, Richard
    Hanes, Justin
    [J]. JOURNAL OF CONTROLLED RELEASE, 2014, 190 : 500 - 514
  • [15] Fabrication and study of curcumin loaded nanoparticles based on folate-chitosan for breast cancer therapy application
    Esfandiarpour-Boroujeni, S.
    Bagheri-Khoulenjani, S.
    Mirzadeh, H.
    Amanpour, Saeed
    [J]. CARBOHYDRATE POLYMERS, 2017, 168 : 14 - 21
  • [16] Interactions of phospholipid bilayer with chitosan: effect of molecular weight and pH
    Fang, N
    Chan, V
    Mao, HQ
    Leong, KW
    [J]. BIOMACROMOLECULES, 2001, 2 (04) : 1161 - 1168
  • [17] Ten years of anti-vascular endothelial growth factor therapy
    Ferrara, Napoleone
    Adamis, Anthony P.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (06) : 385 - 403
  • [18] Chitosan based nanoparticles as protein carriers for efficient oral antigen delivery
    Gao, Ping
    Xia, Guixue
    Bao, Zixian
    Feng, Chao
    Cheng, Xiaojie
    Kong, Ming
    Liu, Ya
    Chen, Xiguang
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2016, 91 : 716 - 723
  • [19] Ion- and pH-activated novel in-situ gel system for sustained ocular drug delivery
    Gupta, Himanshu
    Velpandian, T.
    Jain, Sanyog
    [J]. JOURNAL OF DRUG TARGETING, 2010, 18 (07) : 499 - 505
  • [20] Gupta Swati, 2010, Sci Pharm, V78, P959, DOI 10.3797/scipharm.1001-06